ECSP024410A - Moduladores cilcicos fusionados de la funcion de receptores nucleares hormonales - Google Patents

Moduladores cilcicos fusionados de la funcion de receptores nucleares hormonales

Info

Publication number
ECSP024410A
ECSP024410A EC2002004410A ECSP024410A ECSP024410A EC SP024410 A ECSP024410 A EC SP024410A EC 2002004410 A EC2002004410 A EC 2002004410A EC SP024410 A ECSP024410 A EC SP024410A EC SP024410 A ECSP024410 A EC SP024410A
Authority
EC
Ecuador
Prior art keywords
cilcic
fusioned
modulators
nuclear receptors
receptors function
Prior art date
Application number
EC2002004410A
Other languages
English (en)
Inventor
Mark E Salvati
Jacek Ostrowski
Joyce Driscoll
John Lupisella
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ECSP024410A publication Critical patent/ECSP024410A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Compuestos cíclicos fundidos, los métodos para el empleo de estos compuestos en el tratamiento de condiciones asociadas a receptores nucleares hormonales, como el cáncer y los trastornos inmunes, y preparaciones farmaceúticas conteniendo tales compuestos.
EC2002004410A 2000-06-28 2002-12-27 Moduladores cilcicos fusionados de la funcion de receptores nucleares hormonales ECSP024410A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21439200P 2000-06-28 2000-06-28

Publications (1)

Publication Number Publication Date
ECSP024410A true ECSP024410A (es) 2003-03-31

Family

ID=22798921

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2002004410A ECSP024410A (es) 2000-06-28 2002-12-27 Moduladores cilcicos fusionados de la funcion de receptores nucleares hormonales

Country Status (4)

Country Link
US (1) US20020058290A1 (es)
EC (1) ECSP024410A (es)
IL (1) IL152491A0 (es)
ZA (2) ZA200209530B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003180393A (ja) * 2001-12-13 2003-07-02 Otsuka Pharmaceut Co Ltd レポータージーンアッセイ法
EP1359160A1 (en) * 2002-02-28 2003-11-05 Pfizer Products Inc. Androgen receptor overexpressing skeletal myoblasts
EP1911743B8 (en) * 2005-08-01 2013-01-16 Takeda Pharmaceutical Company Limited Cyclic amine compound
WO2008007664A1 (fr) * 2006-07-11 2008-01-17 Takeda Pharmaceutical Company Limited Composé hétérocyclique bicycique et son utilisation
WO2009136629A1 (ja) * 2008-05-09 2009-11-12 あすか製薬株式会社 生活習慣病予防・治療剤

Also Published As

Publication number Publication date
ZA200209530B (en) 2004-02-23
IL152491A0 (en) 2003-05-29
ZA200210313B (en) 2004-03-19
US20020058290A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
MXPA03002412A (es) Compuestos de succinimida heterociclicos fusionados y analogos de los mismos, moduladores de la funcion del receptor de la hormona nuclear.
UY27595A1 (es) Compuestos de succinimida heterocíclicos, fusionados y analógos de los mismos, moduladores de la función del receptor de la hormona nuclear
GT199800157A (es) Medicamentos.
BR112015018092A2 (pt) moduladores de receptor de nmda de espiro-lactama e usos dos mesmos
AU2002364082A8 (en) Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
AU2002359727A8 (en) Fused cyclic modulators of nuclear hormone receptor function
BR0111869A (pt) Compostos cìclicos fundidos como moduladores da função do receptor para homÈnio nuclear
BR112015018087A2 (pt) moduladores de receptor nmda de espiro-lactama e usos dos mesmos
BR112015018089A2 (pt) moduladores de receptor de nmda de espiro-lactama e usos dos mesmos
BR112015018095A2 (pt) moduladores de receptor nmda de espiro-lactama e usos dos mesmos
UY28342A1 (es) Nuevos compuestos
UY26511A1 (es) Bases de mannich indólicas, procedimientos para su preparación, medicamentos que contienen estos compuestos y su uso para la preparación de medicamentos
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
ECSP024410A (es) Moduladores cilcicos fusionados de la funcion de receptores nucleares hormonales
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
UY26809A1 (es) Moduladores cíclicos fusionados de función de receptor hormonal nuclear
MX9300406A (es) Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen.
ES2173294T3 (es) Nuevo uso medico.
AR023464A1 (es) Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados
AR018321A1 (es) Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
ES2188232T3 (es) Uso de cetirizina para impedir la aparicion del asma.
BR9812002A (pt) Compostos com efeito antiprimeiro-passe